Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)

This is an announcement about a grant opportunity designed to speed up cancer research. The grant is specifically aimed at those currently funded by the National Cancer Institute (NCI) P30 centers. The grant allots funds to back proposals that serve to expand on existing study questions using new or innovative techniques and technologies backed by the NCI's Innovative Molecular Analysis Technologies (IMAT) program.

The purpose of this funding opportunity is to motivate independent validation and improve the applicability of these emerging technologies for cancer research.

The intention is not only to accelerate existing investigations, but also to foster teamwork and partnership among different disciplines. Ultimately, the aim is to fuel the development of innovative methods that will improve cancer research, thus, ushering in new scientific findings more rapidly.